中华整形外科杂志
中華整形外科雜誌
중화정형외과잡지
CHINESE JOURNAL OF PLASTIC SURGERY
2012年
6期
449-453
,共5页
胡纯兵%吴国平%周滨%何小川%兰永树%郭力
鬍純兵%吳國平%週濱%何小川%蘭永樹%郭力
호순병%오국평%주빈%하소천%란영수%곽력
电穿孔%基因疗法%下颌骨%骨生成,牵张%转染
電穿孔%基因療法%下頜骨%骨生成,牽張%轉染
전천공%기인요법%하합골%골생성,견장%전염
Electroporation%Gene therapy%Mandible%Osteogenesis,distraction%Transfection
目的 观察不同时机转染基因对兔下颌骨DO过程中牵引区新生骨骨密度与骨强度的影响,探索基因导入的最佳转染时间,以获得更好的治疗效果.方法 新西兰大白兔48只,全麻下行双侧下颌骨截骨及牵引器植入后,采用随机区组法分成A、B、C、D4组,分别于术后即刻、术后3d(牵引开始时)、牵引结束时,于双侧牵引区分别注射2 μg(0.1 μg/μl)重组质粒pIRES-hBMP2-hVEGF165;A、B、C3组均予电穿孔刺激,D组单纯牵引不行基因转染.各组于术后3d开始以每天0.8 mm、每天1次的速率进行牵引,连续牵引10 d;各组分别于固定期1、2、4、8周处死3只兔子,切取下颌骨行X线片检测、定量CT(quantitative computer tomography,QCT)测量牵引区新生骨组织密度后,将4、8周的标本进行生物力学检测.结果 各组牵引间隙新生骨骨密度与骨强度,随着固定期的延长逐渐增高;固定1周时,A(83.43 ±9.96)、B(92.29±11.25)、C(89.93±14.15)3组新生骨骨密度组间比较,差异无统计学意义(P>0.05),但均高于D组(70.31±3.30),差异有统计学意义(P<0.05);固定2、4、8周时B组骨密度(137.54±7.20、492.93±17.57、790.48±12.19)高于A组(121.44 ±9.27,396.15±15.70,603.39±16.46)、C组(125.06±7.24,464.15±15.45,764.15±17.28)、D(98.86±8.13,336.45±11.95,577.89±18.43),差异有统计学意义(P<0.05),固定4、8周时B组生物力学各项指标均高于A、C、D组(P<0.05).结论 在牵引开始时(牵引期)进行基因转染,能够获得最佳的促进新骨生成的效果,提示牵引期是下颌骨基因治疗的最佳时机.
目的 觀察不同時機轉染基因對兔下頜骨DO過程中牽引區新生骨骨密度與骨彊度的影響,探索基因導入的最佳轉染時間,以穫得更好的治療效果.方法 新西蘭大白兔48隻,全痳下行雙側下頜骨截骨及牽引器植入後,採用隨機區組法分成A、B、C、D4組,分彆于術後即刻、術後3d(牽引開始時)、牽引結束時,于雙側牽引區分彆註射2 μg(0.1 μg/μl)重組質粒pIRES-hBMP2-hVEGF165;A、B、C3組均予電穿孔刺激,D組單純牽引不行基因轉染.各組于術後3d開始以每天0.8 mm、每天1次的速率進行牽引,連續牽引10 d;各組分彆于固定期1、2、4、8週處死3隻兔子,切取下頜骨行X線片檢測、定量CT(quantitative computer tomography,QCT)測量牽引區新生骨組織密度後,將4、8週的標本進行生物力學檢測.結果 各組牽引間隙新生骨骨密度與骨彊度,隨著固定期的延長逐漸增高;固定1週時,A(83.43 ±9.96)、B(92.29±11.25)、C(89.93±14.15)3組新生骨骨密度組間比較,差異無統計學意義(P>0.05),但均高于D組(70.31±3.30),差異有統計學意義(P<0.05);固定2、4、8週時B組骨密度(137.54±7.20、492.93±17.57、790.48±12.19)高于A組(121.44 ±9.27,396.15±15.70,603.39±16.46)、C組(125.06±7.24,464.15±15.45,764.15±17.28)、D(98.86±8.13,336.45±11.95,577.89±18.43),差異有統計學意義(P<0.05),固定4、8週時B組生物力學各項指標均高于A、C、D組(P<0.05).結論 在牽引開始時(牽引期)進行基因轉染,能夠穫得最佳的促進新骨生成的效果,提示牽引期是下頜骨基因治療的最佳時機.
목적 관찰불동시궤전염기인대토하합골DO과정중견인구신생골골밀도여골강도적영향,탐색기인도입적최가전염시간,이획득경호적치료효과.방법 신서란대백토48지,전마하행쌍측하합골절골급견인기식입후,채용수궤구조법분성A、B、C、D4조,분별우술후즉각、술후3d(견인개시시)、견인결속시,우쌍측견인구분별주사2 μg(0.1 μg/μl)중조질립pIRES-hBMP2-hVEGF165;A、B、C3조균여전천공자격,D조단순견인불행기인전염.각조우술후3d개시이매천0.8 mm、매천1차적속솔진행견인,련속견인10 d;각조분별우고정기1、2、4、8주처사3지토자,절취하합골행X선편검측、정량CT(quantitative computer tomography,QCT)측량견인구신생골조직밀도후,장4、8주적표본진행생물역학검측.결과 각조견인간극신생골골밀도여골강도,수착고정기적연장축점증고;고정1주시,A(83.43 ±9.96)、B(92.29±11.25)、C(89.93±14.15)3조신생골골밀도조간비교,차이무통계학의의(P>0.05),단균고우D조(70.31±3.30),차이유통계학의의(P<0.05);고정2、4、8주시B조골밀도(137.54±7.20、492.93±17.57、790.48±12.19)고우A조(121.44 ±9.27,396.15±15.70,603.39±16.46)、C조(125.06±7.24,464.15±15.45,764.15±17.28)、D(98.86±8.13,336.45±11.95,577.89±18.43),차이유통계학의의(P<0.05),고정4、8주시B조생물역학각항지표균고우A、C、D조(P<0.05).결론 재견인개시시(견인기)진행기인전염,능구획득최가적촉진신골생성적효과,제시견인기시하합골기인치료적최가시궤.
Objective To investigate the effect of gene transfection at different time on bone mineral density and strength of newly formed bone in mandibular distraction gap in rabbit,so as to explore the optimal time for gene therapy and enhance the therapeutic effect.Methods 48 New-Zealand rabbits were employed to receive mandibular osteotomy and implantation of distraction devices bilaterly.Then the rabbits were randomly divided into 4 groups as Group A,B and C and D.The animals in group A,B,and C were transfected with recombinant plasmids pIRES-hBMP2-hVEGF165 via eiectroporation-mediated approach at latency period,distraction period,consolidation period respectively.Group D was used as control group without gene transfection.After 3 days of latency period,the distraction devices were activated at the rate of 0.8 mm per day for 10 days.Three rabbits in each group were sacrificed at lwk,2wk,4wk and 8wk of consolidation respectively.The mandibles were harvested and the left mandible received X-ray examination for bone healing,and quantitative computed tomography (QCT) dectection for the bone mineral density (BMD) of newly formed bone in the distraction gap.The biomechanical properties of the new generation bone at 4 th and 8 th week of consolidation in each group were detected by three point bending test.Results The bone mineral density and the biomechanical strength of newly formed bone increased along the length of consolidation in each group.After 1 week of consolidation,there was no significant difference in BMD among group A(83.43 ±9.96),group B(92.29 ± 11.25),group C(89.93 ± 14.15),P >0.05.But the B MD of group A,B and C was higher than that of group D(70.31 ±3.30),P <0.05.After 2wk,4wk and 8wk of consolidation,the BMD of group B (137.54 ± 7.20,492.93 ±17.57,790.48 ± 12.19) was significantly higher than those of group A(121.44 ± 9.27,396.15 ± 15.70,603.39±16.46),C(125.06 ±7.24,464.15 ±15.45,764.15 ±17.28),and D(98.86 ±8.13,336.45 ± 11.95,577.89 ± 18.43),P < 0.05.The biomechanical parameters were also higher in group B than those of group A,C and D after four and eight weeks of consolidation(P < 0.05).Conclusion It is better to transfect gene at the beginning of distraction (distraction period) than at other stages of DO.In this way,more remarkable effect could be obtained on new bone formation.It suggests that the distraction stage is the optimal time for gene therapy.